Axsome Therapeutics AXSM Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's change in lease liabilities?
- Axsome Therapeutics (AXSM) reported change in lease liabilities of -$608K in Q1 2026.
- How has Axsome Therapeutics's change in lease liabilities changed year-over-year?
- Axsome Therapeutics's change in lease liabilities decreased by 392.3% year-over-year, from $208K to -$608K.
- What does change in lease liabilities mean?
- The net change in the company's long-term obligations for leased property.
- How do you interpret change in lease liabilities?
- A decrease indicates the repayment of lease obligations, which is a cash outflow.
- How does change in lease liabilities compare across companies?
- Standardized under accounting rules (ASC 842); comparable across companies with significant real estate footprints.